Usana Health Sciences
USNA
167 hedge funds and large institutions have $528M invested in Usana Health Sciences in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 19 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 50
1.24% more ownership
Funds ownership: 53.26% → 54.5% (+1.2%)
3% less funds holding
Funds holding: 172 → 167 (-5)
8% less capital invested
Capital invested by funds: $573M → $528M (-$45.5M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
27% less call options, than puts
Call options by funds: $148K | Put options by funds: $202K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.77M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.94M |
| 3 |
Morgan Stanley
New York
|
+$2.57M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$2.35M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$4.49M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.78M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.66M |
| 4 |
SGI
Summit Global Investments
Bountiful,
Utah
|
-$1.61M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.14M |
USNA Hedge Fund Activity: Q4 2022 in Review
167 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2022, worth a combined $528M — down 7.9% from $573M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of USNA and 16 opened new positions — a net loss of 3 holders — while 50 trimmed existing stakes and 68 added.
The largest buyer was BlackRock, adding an estimated $6.77M. The largest seller was Renaissance Technologies, cutting an estimated $4.49M.
- 167 institutional investors held Usana Health Sciences (USNA) as of Q4 2022, down from 172 in Q3 2022.
- Funds reported $528M of Usana Health Sciences stock for Q4 2022, down 7.9% quarter-over-quarter.
- 16 funds opened new Usana Health Sciences positions in Q4 2022 and 19 closed out, a net change of -3 holders.
- The largest Usana Health Sciences buyer in Q4 2022 was BlackRock, an estimated $6.77M added.
- The largest Usana Health Sciences seller in Q4 2022 was Renaissance Technologies, an estimated $4.49M sold.
Based on aggregated 13F filings for Q4 2022.